Zobrazeno 1 - 8
of 8
pro vyhledávání: '"NCE, new chemical entity"'
Autor:
Thilo Faber, Yann Pellequer, Marius Monschke, Alf Lamprecht, Karl G. Wagner, Anna K. Krome, Rafael D. Bachmaier, Edmont Stoyanov
Publikováno v:
International Journal of Pharmaceutics: X, Vol 3, Iss, Pp 100076-(2021)
International Journal of Pharmaceutics: X
International Journal of Pharmaceutics: X
Using polymers as additives to formulate ternary amorphous solid dispersions (ASDs) has successfully been established to increase the bioavailability of poorly soluble drugs, when one polymer is not able to provide both, stabilizing the drug in the m
Autor:
Debdutta Bandyopadhyay, Sameer Agarwal, Vismit Vyas, Jignesh P. Pethani, Poonam Giri, Hardik A. Shah, Rajiv P. Sharma, Mukul R. Jain, Santosh Sasane, Kasinath Viswanathan, Harsh Bhavsar
Publikováno v:
Bioorganic & Medicinal Chemistry Letters
Graphical abstract
NLRP3 inflammasome mediated release of interleukin-1β (IL-1β) has been implicated in various diseases, including COVID-19. In this study, rationally designed alkenyl sulfonylurea derivatives were identified as novel, potent
NLRP3 inflammasome mediated release of interleukin-1β (IL-1β) has been implicated in various diseases, including COVID-19. In this study, rationally designed alkenyl sulfonylurea derivatives were identified as novel, potent
Publikováno v:
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica B, Vol 4, Iss 5, Pp 333-349 (2014)
Acta Pharmaceutica Sinica B, Vol 4, Iss 5, Pp 333-349 (2014)
Lipid-based formulations have been an attractive choice among novel drug delivery systems for enhancing the solubility and bioavailability of poorly soluble drugs due to their ability to keep the drug in solubilized state in the gastrointestinal trac
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Kniha
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bachmaier RD; Department of Pharmaceutical Technology and Biopharmaceutics, University of Bonn, 53121 Bonn, Germany., Monschke M; Department of Pharmaceutical Technology and Biopharmaceutics, University of Bonn, 53121 Bonn, Germany., Faber T; Department of Pharmaceutical Technology and Biopharmaceutics, University of Bonn, 53121 Bonn, Germany., Krome AK; Department of Pharmaceutical Technology and Biopharmaceutics, University of Bonn, 53121 Bonn, Germany., Pellequer Y; UFR Santé, Laboratoire de Pharmacie Galénique, 19, rue Ambroise Paré, 25000 Besancon, France., Stoyanov E; Nisso Chemical Europe GmbH, Berliner Allee 42, 40212 Düsseldorf, Germany., Lamprecht A; Department of Pharmaceutical Technology and Biopharmaceutics, University of Bonn, 53121 Bonn, Germany.; UFR Santé, Laboratoire de Pharmacie Galénique, 19, rue Ambroise Paré, 25000 Besancon, France., Wagner KG; Department of Pharmaceutical Technology and Biopharmaceutics, University of Bonn, 53121 Bonn, Germany.
Publikováno v:
International journal of pharmaceutics: X [Int J Pharm X] 2021 Mar 17; Vol. 3, pp. 100076. Date of Electronic Publication: 2021 Mar 17 (Print Publication: 2021).
Autor:
Kollipara S; Formulations Department, Pharmaceutical & Analytical Development, Technical R&D, Novartis Healthcare Pvt. Ltd., Hyderabad 500078, Andhra Pradesh, India., Gandhi RK; Formulations Department, Pharmaceutical & Analytical Development, Technical R&D, Novartis Healthcare Pvt. Ltd., Hyderabad 500078, Andhra Pradesh, India.
Publikováno v:
Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2014 Oct; Vol. 4 (5), pp. 333-49. Date of Electronic Publication: 2014 Oct 08.